Physician profile
Ileana Berman
NPI 1245277961
$4,439.15
in general payments reported to CMS, 2019-2025
15 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,964 · 2020: $838 · 2021: $187 · 2022: $333 · 2024: $14.92 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,363.80 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $541.83 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $511.01 | 2019-2021 | |
| Abbvie INC. | $497.54 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $415.79 | 2019 | |
| Neurocrine Biosciences, INC. | $298.82 | 2019-2020 | |
| Alkermes, INC. | $183.92 | 2019-2020 | |
| Allergan, INC. | $158.55 | 2019-2020 | |
| Shire North American Group INC | $111.68 | 2019 | |
| Vanda Pharmaceuticals INC. | $107.65 | 2019-2020 | |
| Braeburn INC. | $87.21 | 2025 | Brixadi |
| Orexo US, INC. | $73.52 | 2019-2020 | |
| Lundbeck LLC | $58.10 | 2019-2020 | |
| Neuronetics, INC. | $17.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ileana Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.